Veterinary Clinical Reference
Look up any drug or condition.
Evergreen, evidence-based hubs on the drugs, conditions, and species you manage — continuously updated and cited at every claim.
Telmisartan (Semintra) for Proteinuria and Hypertension in Cats with CKD
Evergreen clinical reference on telmisartan (Semintra) for feline CKD proteinuria and systemic hypertension: the pivotal 224-cat RCT vs benazepril, FDA/EMA indications, ARB pharmacology and PK, contested aldosterone-suppression-test data, 2026 circulating-RAAS findings, and IRIS 2023 staging, phosphate, and monitoring guidance for licensed DVMs.
Read →Mirtazapine Transdermal Ointment (Mirataz) for Feline Weight Loss
FDA-approved mirtazapine transdermal ointment (Mirataz) for feline weight loss: pivotal field-study results, receptor mechanism, and lymphoma, CKD, and owner-adherence evidence. Includes dosing, the MAOI contraindication, and comparator guidance.
Read →Gabapentin for Pre-Visit Feline Anxiety: Evidence and Clinical Use
The evergreen clinical reference on gabapentin in cats: randomized and systematic-review evidence for pre-visit anxiolysis, the ~40% ataxia rate and 8-hour resolution window, cardiovascular safety, the pregabalin comparison, and the emerging atopic-dermatitis adjunct signal.
Read →Frunevetmab (Solensia) for Feline Osteoarthritis: Efficacy and Real-World Safety
A clinician's evidence hub on frunevetmab (Solensia) for feline OA pain: the Gruen 2021 pivotal RCT and real-world quality-of-life data on efficacy, plus RCT and FDA-database adverse-event signals (predominantly dermatological, with unconfirmed neurological and joint signals).
Read →